Data as of Jan 23
| -0.09 / -3.02%|
The 4 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 2.75, with a high estimate of 6.00 and a low estimate of 1.50. The median estimate represents a -4.84% decrease from the last price of 2.89.
The current consensus among 4 polled investment analysts is to Hold stock in Corcept Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.